Finance

Lists
Why is 531146 down 2.83%?
Dive Deeper
531146:BOM
Medicamen Biotech Ltd
₹288.55
-2.83%
(-8.40) 1D
Oct 16, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
₹287.00
High
₹290.00
Low
₹282.15
Mkt. cap
3.87B
Avg. vol.
5.49K
Volume
885.00
Dividend
0.35%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 18, 2026
P/E ratio
33.23
52-wk high
₹454.00
52-wk low
₹210.10
EPS
₹8.68
Shares outstanding
11.70M
No. of employees
405
Open
₹287.00
High
₹290.00
Low
₹282.15
Mkt. cap
3.87B
Avg. vol.
5.49K
Volume
885.00
Dividend
0.35%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 18, 2026
P/E ratio
33.23
52-wk high
₹454.00
52-wk low
₹210.10
EPS
₹8.68
Shares outstanding
11.70M
No. of employees
405
News stories
From web sources and news partners
About Medicamen Biotech Ltd
CEO-
Employees405
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitemedicamen.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
475.43M
474.43M
592.69M
487.58M
Cost of goods sold
231.53M
237.10M
349.40M
211.20M
Cost of revenue
231.53M
237.10M
349.40M
211.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88.31M
83.73M
146.78M
93.14M
Operating expense
207.18M
206.51M
219.99M
242.38M
Total operating expenses
438.71M
443.61M
569.39M
453.58M
Operating income
36.72M
30.83M
23.30M
34.01M
Other non operating income
-
1.00K
8.26M
-
EBT including unusual items
26.83M
21.11M
50.60M
25.72M
EBT excluding unusual items
26.83M
21.11M
50.56M
25.72M
Income tax expense
5.69M
4.76M
6.13M
7.26M
Effective tax rate
21.19%
22.56%
12.11%
28.22%
Other operating expenses
100.30M
104.51M
55.88M
131.37M
Net income
26.67M
21.87M
37.39M
21.18M
Net profit margin
5.61%
4.61%
6.31%
4.34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
17.39M
-
Interest expense
-9.89M
-9.72M
-3.83M
-8.29M
Net interest expenses
-9.89M
-9.72M
13.56M
-8.29M
Depreciation and amortization charges
18.57M
18.27M
17.33M
17.87M
EBITDA
55.01M
48.10M
40.92M
52.05M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps